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ABSTRACT
The picornavirus foot-and-mouth disease virus (FMDV) is the etiological agent of a highly contagious disease that affects impor-
tant livestock species. The FMDV capsid is highly acid labile, and viral particles lose infectivity due to their disassembly at pH
values slightly below neutrality. This acid sensitivity is related to the mechanism of viral uncoating and genome penetration
from endosomes. In this study, we have analyzed the molecular basis of FMDV acid-induced disassembly by isolating and char-
acterizing a panel of novel FMDVmutants differing in acid sensitivity. Amino acid replacements altering virion stability were
preferentially distributed in two different regions of the capsid: the N terminus of VP1 and the pentameric interface. Evenmore,
the acid labile phenotype induced by a mutation located at the pentameric interface in VP3 could be compensated by introduc-
tion of an amino acid substitution in the N terminus of VP1. These results indicate that the acid sensitivity of FMDV can be con-
sidered a multifactorial trait and that virion stability is the fine-tuned product of the interaction between residues from different
capsid proteins, in particular those located within the N terminus of VP1 or close to the pentameric interface.
IMPORTANCE
The viral capsid protects the viral genome from environmental factors and contributes to virus dissemination and infection.
Thus, understanding of the molecular mechanisms that modulate capsid stability is of interest for the basic knowledge of the
biology of viruses and as a tool to improve the stability of conventional vaccines based on inactivated virions or empty capsids.
Using foot-and-mouth disease virus (FMDV), which displays a capsid with extreme acid sensitivity, we have performed a genetic
study to identify the molecular determinants involved in capsid stability. A panel of FMDVmutants with differential sensitivity
to acidic pH was generated and characterized, and the results showed that two different regions of FMDV capsid contribute to
modulating viral particle stability. These results provide new insights into the molecular mechanisms of acid-mediated FMDV
uncoating.
Foot-and-mouth disease virus (FMDV) is the etiological agentof a highly contagious disease that affects important livestock
species such as swine, cattle, sheep, and goats (1, 2). This virus is
the type species of theAphthovirus genuswithin the Picornaviridae
family. The FMDV genome consists of a single-stranded positive-
sense RNA molecule of about 8.5 kb in length (3). Like those of
other RNA viruses, FMDV populations are complex and dy-
namic distributions of variants termed quasispecies that ex-
hibit a high potential for variation and adaptation, which is
reflected in the seven serotypes and the multiple antigenic vari-
ants identified (4, 5).
The viral capsid contains 60 copies of each of the four struc-
tural proteins (VP1 to VP4) arranged into 12 pentameric subunits
that constitute intermediates of capsid assembly and disassembly
(6, 7). An intriguing feature of the FMDV capsid is the extreme
sensitivity to acidic pH, which results in virus inactivation after
exposure of virions to mildly acidic pH (8). At pH slightly below
neutrality, FMDV capsid disassembles into pentameric subunits
(9) and there is good correlation between loss of infectivity by in
vitro exposure to acidic pH and capsid dissociation (10–12). The
acid sensitivity of FMDV has been related to the mechanism of
virus penetration in host cells (13–15); the current model sup-
ports the hypothesis that the acidification of endosomes, where
FMDV virions are sorted, triggers viral uncoating and genome
release (16–18). Consistently, blockage of endosome acidification
using the lysosomotropic weak base ammonium chloride
(NH4Cl), which acts as a proton sink within the endosomes (19,
20), inhibited FMDV infection by impairing virus uncoating
without affecting virus binding or entry (10, 13, 21). We previ-
ously reported that under the conditions of impaired acidification
of endosomes in cells treated with NH4Cl, FMDV variants with
enhanced acid sensitivity could be selected (10). The analysis of
these mutants revealed that the mechanism to escape the inhibi-
tory effect of NH4Cl was based on the elevation of the uncoating
pH (9, 13). On the other hand, point mutations in the viral capsid
can enhance acid resistance by lowering the pH required for un-
coating (11, 12, 22–24). One such amino acid substitution, N17D,
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which is located at the N terminus of VP1, has been selected in
three different serotypes (11, 23, 24).
In this study, we have further analyzed the genetic determi-
nants of the pH stability of the FMDV capsid by isolating and
characterizing a novel panel of acid-labile mutants. Amino acid
replacements altering virion stabilitywere preferentially located in
two well-defined regions of the capsid: the N terminus of VP1 and
the pentameric interface. Furthermore, the acid-labile phenotype
induced by a mutation in VP3 (A116V) located at the pentameric
interface could be compensated by the rational introduction of an
amino acid substitution in a different capsid region: the internal N
terminus of VP1 (N17D). These results indicate that these two
capsid regions modulate the acid stability of FMDV particles.
MATERIALS AND METHODS
Cells, viruses, animal samples, infections, and virus titrations. The ori-
gin of BHK-21 cells and culture procedures have been described previ-
ously (18, 25). The C-S8c1 isolate is a biological clone from type C FMDV
(26). Mutants m6 and c2 are two C-S8c1 variants with increased acid
resistance and enhanced acid sensitivity, respectively (10, 11). O1K is a
type O FMDV recovered from the infectious clone pO1K (27). Vesicular
fluid from a lesion (aphtha) developed in a pig experimentally infected
with 104 PFU of FMDV C-S8c1 and collected at 3 days postinfection was
used (28). Procedures for infections in liquid medium and virus titration
in semisolid agar medium were as described previously (10, 18).
Acid-induced inactivation assays. A previously published protocol
was followed (10). Briefly, equal amounts of viral samples (PFU) were
mixedwith phosphate-buffered saline (PBS) solutions of different pHs for
30 min at room temperature, pH was neutralized with 1 M Tris (pH 7.6),
and the remaining infectivity in each sample was determined by titration
in BHK-21 cells.
Inhibition of endosomal acidification with NH4Cl. Cell monolayers
were treated 1 h prior to infection with 25mMNH4Cl in culture medium
supplemented with 25 mM HEPES at pH 7.4 to buffer extracellular pH,
and the drug was maintained throughout the rest of the assay (10).
Nucleotide sequencing and site-directed mutagenesis of infectious
cDNA clones. Viral RNA extraction, cDNA synthesis, amplification by
reverse transcription-PCR (RT-PCR), and DNA sequencing were per-
formed as described previously (10). Nucleotide positions correspond to
those in the sequences of FMDV C-S8c1 (GenBank accession number
AJ133357.1) or O1K (GenBank accession number X00871.1) (29, 30).
Selected nucleotide substitutions were introduced into infectious cDNA
clone pMT28, which contains the complete coding sequence of C-S8c1
(31). pMT28-VP3 A116V was constructed by introducing the DNA frag-
ment containing nucleotides located between the SfiI andAvrII restriction
sites of mutant av1 into pMT28. To this end, cDNA was amplified from
av1 RNA by RT-PCR, digested with SfiI and AvrII (New England Bio-
Labs), ligated into pMT28 digested with the same enzymes, and used to
transform Escherichia coli DH5 as described previously (10). To con-
struct the double mutant pMT28-VP3 A116V  VP1 N17D, the region
encompassing the DNA fragment located between nucleotides 1804 and
3946 of the C-S8c1 genome was amplified by PCR from plasmid pMT28-
VP1 N17D (11) and subcloned into pGEM-T easy vector (Promega) by
following the instructions provided by themanufacturer. This intermedi-
ate vector, termed pGEM-VP1 N17D, was used as a template to conduct
site-directed mutagenesis using the QuikChange II kit (Agilent) and
oligonucleotide primers GGGCCGACCGACGTGAAAGCTCGGTAC
ATGG and CCATGTACCGAGCTTTCACGTCGGTCGGCCC. The nu-
cleotide substitution introduced is in italics. Plasmid pGEM-VP1 N17D 
VP3 A116V resulting from site-directed mutagenesis was digested with
SfiI and AvrII, ligated into pMT28 digested with the same enzymes, and
used to transform E. coli DH5. Infectious clones pMT28-VP1 V11I,
pMT28-VP1 T12A  VP1 N17D, pMT28-VP3 A116T  VP3 A118V 
VP1 N17D, and pMT28-VP3 A116V  VP1 N17D  VP1 T22N were
engineered by placing into pMT28 the corresponding DNA fragments
located between SfiI and AvrII sites that were amplified by RT-PCR from
the viral populations carrying thesemutations. Viral RNAwas synthesized
from infectious cDNA clones and used to transfect BHK-21 cells (10). The
nucleotide sequences of engineered cDNA clones and viruses were con-
firmed by DNA sequencing.
Molecular graphics and structure analysis. The atomic coordinates
of FMDV C-S8c1 (32) and O1 (33) were used. Structures were visualized
using PyMol Molecular Graphics System version 1.5.0.4 (Schrödinger,
LLC). Contact information of selected residues was obtained using
VIPERdb (34). Amino acid residues were numbered according to FMDV
C-S8c1 or O1K sequences, as described above.
Data analysis. Data are presented as means  standard deviations
(SD). Analysis of variance (ANOVA)was performed using SPSS 15 (SPSS,
Inc.). Bonferroni’s correction was applied for multiple comparisons. Sta-
tistically significant differences are indicated in figures by one asterisk for
a P value of0.05 or two asterisks for a P value of0.005.
RESULTS
A novel FMDV mutant with increased acid sensitivity directly
isolated froman animal sample.TreatmentwithNH4Cl has been
successfully used to isolate FMDV mutants with enhanced acid
sensitivity from cell culture-passaged viral populations (10). Go-
ing one step further, we explored the possibility to isolate FMDV
mutants with increased acid sensitivity directly from animal le-
sions. To this end, vesicular fluid collected from an aphtha devel-
oped in a pig experimentally infected with type C FMDV C-S8c1
was used. The consensus sequence of the capsid coding region of
the virus contained in this sample showed no differences from the
sequence of the parental C-S8c1. Tenfold serial dilutions of this
vesicular fluid were plated in parallel in BHK-21 cells treated or
not with 25 mM NH4Cl. Lysis plaques were developed in both
control and NH4Cl-treated cells, although the amount of PFU
recovered from vesicular fluid was about 2 orders of magnitude
lower in cells treated with NH4Cl than in control cells (Fig. 1A).
Five viral plaques developed in NH4Cl-treated cells (clones av1 to
av5) were successfully amplified by infection in liquid medium
containing NH4Cl. The nucleotide sequence of the capsid coding
region of these viruses was determined and compared to that of
the parental C-S8c1 virus. The single nucleotide substitution
C2897T leading to amino acid replacementVP3A116Vwas found
in clones av1 to av5; this substitution was not detected in the
consensus sequence of the parental population of the vesicular
fluid. Interestingly, replacement VP3 A116V was located very
close to replacement VP3 A118V previously found in the acid-
labile mutant c2 (10). Since av1 to av5 carried the same capsid
sequence, virus av1 was selected for subsequent analyses and its
acid sensitivity was compared with that of the parental C-S8c1 in
inactivation assays (Fig. 1B). In these experiments, two derivatives
of C-S8c1, one with increased acid resistance (m6, which carries
replacement VP1 N17D [11]) and the other with enhanced acid
sensitivity (c2, which carries replacement VP3 A118V [10]), were
included as controls. The infectivity of av1 was significantly re-
duced by treatment with pH 6.7 compared to that of C-S8c1, thus
confirming that this mutant, directly isolated from an animal le-
sion, displayed enhanced acid sensitivity.
Amino acid replacement VP3 A116V confers an increase in
acid sensitivity that can be compensated by the introduction of
amino acid replacement VP1 N17D. Amino acid replacement
VP3 A116V, responsible for the increase in acid lability of mutant
av1, was located close to the pentameric interface (Fig. 2A).On the
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other hand, we had previously reported that replacement VP1
N17D found in C-S8c1 variant m6 increased the acid resistance of
virions (11). VP1 N17D was located about 25 Å from VP3 A116V
in an internal part of the capsid (Fig. 2A and B). To study whether
VP1 N17D replacement could compensate the acid-labile pheno-
type conferred by replacement VP3 A116V, the nucleotide substi-
tution responsible for VP3 A116V was introduced either alone or
combined with that of VP1 N17D into the infectious clone
pMT28, which contains the complete coding sequence of FMDV
C-S8c1 (29). In this way, infectious clones pMT28-VP3 A116V
and pMT28-VP3 A116V  VP1 N17D were engineered, and the
corresponding viruses were recovered by transfection of BHK-21
cells with in vitro-synthesized viral RNAs. The VP3 A116VVP1
N17D double mutant and VP3 A116V single mutant were viable,
both developed lysis plaques in BHK-21 cells (Fig. 2C), and both
were genetically stable after 10 passages in BHK-21 cells without
accumulating any additional replacement. In this experiment, the
parental virus recovered from infectious clone pMT28 (C-S8c1)
and the VP3 A118V (10) and VP1 N17D (11) single mutants were
included as controls. No significant differences in plaque size were
found amongmutant viruses and C-S8c1, except for a significant,
albeit slight, reduction in the plaque size of the virus encoding
amino acid replacement VP3A118V, which is consistent with pre-
vious results showing that introduction of this replacement re-
sulted in a slight reduction of plaque size (10). In addition, no
major differences in the viral growth curves of these viruses were
noticed (Fig. 2D). The acid resistance of the mutant viruses was
analyzed, and the pH50 values (defined as the pH that causes a loss
of 50% of the infectivity), which constitute a useful indication of
acid resistance (10–12), were calculated and compared to that of
C-S8c1 (Fig. 2E). As expected, virus carrying VP1 N17D at the N
terminus of VP1 was the most acid-resistant virus (pH50, 6.13
[11]). In contrast, the most acid-labile viruses were those carrying
amino acid replacements VP3 A116V and VP3 A118V (pH50s,
6.87 and 6.93 [10], respectively). The VP3 A116V  VP1 N17D
double mutant (pH50, 6.67) displayed an intermediate phenotype
between acid-resistant and acid-labile viruses, with an inactiva-
tion profile similar to that of C-S8c1 virus (pH50, 6.65 [10, 11]).
Therefore, these results indicated that the introduction of replace-
ment VP1 N17D into a highly acid-labile capsid carrying replace-
ment VP3 A116V increased virion acid resistance to a level similar
to that of the parental C-S8c1 virus, with minor effects on viral
growth.
C-S8c1 variants passaged in the presence ofNH4Cl select dif-
ferent amino acid replacements that increase acid lability of vi-
rions.The genetic determinants of capsid destabilization thatme-
diate adaptation of FMDV to grow under conditions of impaired
endosome acidification were further addressed. C-S8c1 and mu-
tant viruses carrying amino acid replacements VP1 N17D or VP3
A116V VP1 N17D were recovered from the corresponding in-
fectious clones and subjected to serial passages in BHK-21 cells in
the presence of NH4Cl until a cytopathic effect was detectable
(usually about 18 h postinfection). The virus harboring the single
replacement VP3 A116V was not included in these assays since
this mutant already displayed a highly acid-labile capsid (Fig. 2E).
Viral RNA was extracted and the consensus nucleotide sequence
of the capsid coding region of each viral population was analyzed
at passage 10 (Table 1). When no nucleotide substitution was
found imposed in the viral population, the corresponding viruses
were subjected to 10 additional passages (Table 1, asterisks). These
series of experiments were performed in triplicate for each virus.
All viruses analyzed retained the initial mutations and acquired
upon passaging replacements at different capsid residues, except
the VP3 A116V VP1 N17Dmutant in experiment 2, in which a
pseudoreversion of one of the amino acid replacements engi-
neered in this virus (VP1 D17G) was found. Amino acid replace-
ments were accumulated in VP3 or VP1, except for VP2 G193C in
experiment 2 with the VP1 N17D mutant. Interestingly, two re-
placements involving the sameVP1 residue (T12A andT12I) were
found in two different populations (experiment 1 with the VP1
N17D mutant and experiment 3 with the VP3 A116V  VP1
N17D mutant, respectively). It is remarkable that the viral popu-
lation resulting from experiment 3 with the VP1 N17D mutant
accumulated two additional nucleotide substitutions responsible
FIG 1 Characterization of FMDV mutants isolated in the presence of NH4Cl from vesicular fluid of an FMDV-infected pig. (A) Lysis plaques developed by
viruses recovered in the absence or in the presence of NH4Cl. BHK-21 cells were treated or not with 25mMNH4Cl, and 10-fold serial dilutions of vesicular fluid
from a pig experimentally infected with FMDV C-S8c1 were plated. Cell monolayers were fixed and stained with crystal violet at 30 h postinfection to visualize
lysis plaques. The dilution of the viral sample is indicated in each case. (B)Acid inactivation assays ofmutant viruses isolated fromvesicular lesions in the presence
of NH4Cl. Equal amounts of the different viruses (C-S8c1, av1, c2, or m6) were treated with PBS at pH 7.5, 6.7, or 6.4, neutralized, and plated on BHK-21 cells.
Infectivity was calculated as the percentage of PFU recovered at each different pH relative to that obtained at pH 7.5. av1 is an individual biological clone
recovered from vesicular fluid. m6 and c2 are two C-S8c1 variants with increased acid resistance and enhanced acid lability, respectively (10, 11). Statistically
significant differences between C-S8c1 and mutant viruses are indicated by one asterisk for a P value of0.05 or two asterisks for a P value of0.005.
Novel FMDV Mutants with Different Acid Sensitivities
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for the introduction of replacements at residues important for the
acid stability of the viral capsid (reference 10 and this report). One
of them, VP3 A118V, had been previously found in acid-labile
mutant c2 (10), while VP3A116Twas different from that found in
mutant av1 (A116V).When the selection of the nucleotide substi-
tutions responsible for replacements VP3 A116T and VP3 A118V
was traced along passages, the twomutations were simultaneously
detected in passage 3 and became dominant from passage 4 (data
not shown).
The mutant populations passaged in the presence of NH4Cl
displayed significantly increased acid sensitivities relative to those
of the parental populations (Fig. 3). These results support the
FIG 2 Amino acid substitution VP1 N17D compensates the acid-labile phenotype conferred by amino acid replacement VP3 A116V. (A) Location on the
structure of C-S8c1 capsid of amino acid substitutions VP3 A116V and VP1 N17D. An inside schematic view of a pentameric subunit showing only amino acid
main chains is shown. VP1 is green, VP2 is magenta, VP3 is cyan, and VP4 is yellow. (B) Inside schematic view of a biological protomer of C-S8c1 showing the
location of amino acid substitutions in panel A. VP4 is not shown, for clarity. The distance betweenVP1N17 andVP3A116 is shown. The positions of 5-fold and
3-fold symmetry axes are indicated by a pentagon and a triangle, respectively. (C) Analysis of the plaque size of viruses recovered from infectious clone pMT28
(wild type [WT]) and its derivatives encoding amino acid substitutions VP3 A116V, VP3 A118V, VP1 N17D, and VP3 A116V VP1 N17D. BHK-21 cells were
infected in semisolid agar medium, and plaques were visualized by staining with crystal violet. About 100 viral plaques were analyzed for each virus. Double
asterisks indicate statistically significant differences between the mutants and the WT (ANOVA, P 0.005). (D) Single-step growth curve analysis of FMDVs
recovered from the infectious clones indicated in panel C. BHK-21 cells were infected (multiplicity of infection [MOI] of 1 PFU/cell), and the virus titer in the
supernatants was determined by plaque assay at different times postinfection. (E) Acid sensitivity of viruses recovered from infectious clone pMT28 and its
derivatives shown in panel C. Equal amounts (PFU) of the different viruses were treated with PBS at different pHs for 30min and the pHwas neutralized and the
remaining infectivity was titrated using BHK-21 cells and semisolid agar medium. Infectivity was calculated as the percentage of PFU recovered at each different
pH relative to that obtained at pH 7.3. The intersection between the inactivation curves and the dashed lines indicates pH50 values; see the text for details.
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notion that despite the initial genetic background, the amino acid
replacements selected upon the passages are responsible for acid-
labile phenotypes to cope with the impaired endosomal acidifica-
tion exerted by NH4Cl.
Amino acid replacements selected in C-S8c1 variants pas-
saged in the presence of NH4Cl cluster in the pentameric inter-
face or in the N terminus of VP1. The amino acid replacements
acquired by the viruses passaged in the presence of NH4Cl (Table
1) were mapped to the C-S8c1 structure (Fig. 4A). Four amino
acid replacements, one in VP2 (G193C) and three in VP3 (D115E,
A116T, and A118V), were located close to the pentameric inter-
face, a region involved in capsid stability (10, 35). On the other
hand, all amino acid replacements found in VP1 (V11I, T12A,
T12I, D17G, Y18H, and T22N) were located within the internal
part of the capsid at the N terminus of this protein, emphasizing
the involvement of this region in the acid stability of the FMDV
capsid. To demonstrate that the mutations found in NH4Cl-pas-
saged viruses were responsible for the increase in acid sensitivity,
four amino acid combinations found in these naturally selected
mutants were introduced into plasmid pMT28. Thus, infectious
clones pMT28-VP1 V11I, pMT28-VP1 T12A VP1 N17D,
pMT28-VP3 A116T  A118V  VP1 N17D, and pMT28-VP3
A116V  VP1 N17D  VP1 T22N were constructed, and the
corresponding viruses were recovered after transfection of in
vitro-synthesized viral RNAs. The acid sensitivities of these viruses
were analyzed and compared in each case with that of the parental
virus (Fig. 4B to D). The virus carrying replacement VP1 V11I
displayed an acid-labile profile (pH50, 6.92) compared to C-S8c1
(pH50, 6.65) (Fig. 4B), confirming that VP1 V11I was responsible
for its acid-labile phenotype. Likewise, introduction of replace-
ment VP1 T12A or VP3 A116T  A118V into the genetic back-
ground of the acid-resistant VP1 N17D virus resulted in an eleva-
tion of the pH50 from 6.13 (VP1 N17D) to 6.9 and 6.93 for VP3
A116T  A118V  VP1 N17D and VP1 T12A  N17D viruses,
respectively (Fig. 4C). In addition, the introduction of replace-
ment VP1 T22N in the genetic background of VP3 A116V VP1
N17D virus also increased its acid sensitivity, raising the pH50
from 6.67 for the VP3 A116V VP1 N17D mutant to 6.9 for the
VP3 A116V  VP1 N17D  T22N mutant (Fig. 4D). Taken to-
gether, these results confirm that the pentameric interface and the
VP1 N terminus define two capsid regions key for the control of
acid stability of FMDV capsid, and that different amino acid sub-
stitutions in these regions can modulate this phenotype.
Mutations in VP3 or at the N terminus of VP1 canmodulate
the acid resistance of type O FMDV. To study if the results ob-
tained with type C could be extrapolated to other FMDV sero-
types, we isolated and characterized type O FMDV mutants with
increased acid sensitivity. Tenfold serial dilutions of O1K FMDV
were plated in parallel in cells treated or not with 25 mM NH4Cl.
As for type C FMDV, lysis plaques were developed by FMDVO1K
in both control and treated cell monolayers; the amount of PFU
recovered in cells treated with NH4Cl was about 2 orders of mag-
nitude lower than that of control cells. Complete sequencing of
the capsid coding region from four FMDV clones selected from
NH4Cl-treated cells (fc4, fc9, fc11, and fc13) showed that they
carried nucleotide substitutions leading to amino acid replace-
ments in either the VP3 or VP1 N terminus as the only mutations
present in their capsids (Table 2). Two of them displayed nucleo-
tide substitutions introducing amino acid replacements into theN
terminus of VP1 (T12N in fc4 and T2A in fc13). The other two
mutants (fc9 and fc11) carried the same nucleotide substitution
leading to replacement VP3 T156A, so only the fc9 mutant was
included in further experiments. The replacements were shown to
be located very close to each other in the structure of type O
FMDV capsid (Fig. 5A). The acid sensitivity of these mutants was
compared with that of the parental O1K virus (Fig. 5B). The three
mutants displayed an increase in acid sensitivity (pH50s, 6.76,
6.81, and 6.97 for viruses carrying amino acid replacements VP3
T156A, VP1 T12N, and VP1 T2A, respectively) compared with
O1K (pH50, 6.53), confirming that the introduction of these re-
placements in the viral capsid increased the acid lability of type O
FMDV.
DISCUSSION
Understanding the molecular basis that control capsid stability is
relevant not only for the knowledge of a basic aspect of FMDV
biology, but also to gain information to improve stability of con-
ventional vaccines based on inactivated virions (12, 36) or future
vaccines based on empty capsids (37). In this study, we have iso-
lated a panel of FMDVmutants with increased sensitivity to acidic
pH by performing infections in the presence of NH4Cl. A mutant
isolated from vesicular fluid of an infected animal carried amino
TABLE 1Mutations selected in the capsid coding regions of type C FMDV variants after serial passage in the presence of NH4Cl
Parental virus Exptb
Mutation(s) selected in viral capsid proteina
VP4 VP2 VP3 VP1
Wild type (C-S8c1) 1 C2895A D115E*
2 T3259C Y18H*
3 G3238A V11I
VP1 N17D mutant 1 A3241G T12A
2 G2473T G193C
3 G2896T A116T
C2903T A118V
VP3 A116V VP1 N17D mutant 1 C3272A T22N
2 A3257G D17G*
3 C3242T T12I*
a In each case the nucleotide substitution and corresponding amino acid replacement (in bold) found after serial passages in the presence of 25 mM NH4Cl are indicated relative to
the corresponding parental population. Numbering is as for the C-S8c1 genome (29). Nucleotide substitutions were found in viral populations after 10 serial passages or after 10
additional passages (a total of 20 passages). An asterisk indicates a nucleotide substitution detected upon 20 serial passages not found dominant at passage 10.
b Numbers in the experiment column are individual passage series.
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acid replacement VP3 A116V, which mapped close to replace-
ments VP3 A118V and VP3 A123T, which were found in two
acid-labile mutants previously isolated from a cell culture-ampli-
fied FMDV stock (10). These three amino acid replacements were
located along -sheet E of VP3 very close to the pentameric inter-
face, suggesting a common mechanism for their modes of action.
As in the case of VP3 A118V and A123T, the small side chain of
VP3 A116 is completely buried, and the substitution introduces a
bulkier side chain whose accommodation into VP3 probably re-
quires some deformation of the protein that alters pentamer-pen-
tamer interactions, thus increasing the acid lability of the capsid
(10).
Amino acid replacement VP1 N17D confers acid resistance to
typeC (11) and, as recently reported, to typeO (23) andAsia1 (24)
FMDVs, which makes VP1 N17 an interesting determinant of the
acid stability of the FMDV capsid. Considering the functional re-
lationships between distant amino acid residues described for pi-
cornavirus uncoating (38), we analyzed whether VP1 N17D re-
placement could compensate the acid labile phenotype. Indeed,
introduction ofVP1N17D restored the highly acid-labile virion of
mutant VP3 A116V (pH50, 6.87) to a level (pH50, 6.67) very sim-
ilar to that of the parental C-S8c1 virus (pH50, 6.65). Therefore,
these results suggest that residues placed close to the pentameric
interface, where A116V is located, and the internal VP1 N termi-
nus, where VP1 N17D is placed, modulate the acid sensitivity of
the FMDV capsid.
The analysis of compensatory mutations selected in FMDV
capsids provides insights on the regions that regulate capsid sta-
bility (39). Consistent with this view, serial passage of the different
FMDV variants in the presence of NH4Cl promoted the selection
of diverse mutations that were mostly located at the pentameric
interface (VP2G193C; VP3D115E, A116T, and A118V) or within
the N terminus of VP1 (VP1 V11I, T12I, T12A, D17G, Y18H, and
T22N). Interestingly, in one of these mutants (VP3 A116T), resi-
due VP3 A116 was found to be replaced by a threonine instead of
by the valine observed in the VP3 A116V mutant isolated from
vesicular fluid of an infected animal. This alternative replacement
introduces a bulkier side chain that, as noted above, could alter
FIG 3 Viral populations selected after serial passage in the presence of NH4Cl display acid-labile virions. Shown is a comparison of acid sensitivities of parental
viruses (C-S8c1 in panel A, the VP1 N17Dmutant in panel B, and the VP3 A116VVP1 N17Dmutant in panel C) with mutant viral populations selected after
serial passage in the presence of NH4Cl. Equal amounts of the different viruses (PFU) recovered from infectious clones were treated with PBS at pH 7.5, 6.8, 6.6,
and 6.4, neutralized, and plated on BHK-21 cells. Infectivity was calculated as the percentage of PFU recovered at each different pH relative to that obtained at
pH 7.5. “Exp.” (experiment) indicates an individual passage series. The passage analyzed and the amino acid replacements displayed by the capsid (Table 1) are
indicated in each case. Statistically significant differences between each parental virus andmutant populations are indicated by one asterisk for a P value of0.05
or by two asterisks for a P value of0.005.
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pentamer-pentamer interactions and increase the acid lability of
the capsid. A similar alteration could also explain the effect of the
other neighbor substitutions found near the pentameric interface
(VP2 G193C and VP3 D115E).
The selection of the mutant virus carrying replacements VP3
A116TVP3A118VVP1N17D as a result of the passage of the
VP1 N17D mutant in the presence of NH4Cl merits special con-
sideration. This naturally engineered mutant exploits the combi-
nation of amino acid replacements in the pentameric interface
and in the N terminus of VP1 that was originally behind the ratio-
nale followed to design the VP3 A116VVP1 N17D double mu-
tant. Hence, this mutant reinforces the mechanistic connection
between these regions of the capsid to modulate pH stability. The
complete series of mutants related to this virus goes from the
acid-resistant VP1 N17D mutant (pH50, 6.13) to the acid-labile
VP3 A116T  VP3 A118V  VP1 N17D mutant (pH50, 6.9),
whose pH50 was similar to those of the acid-labile VP3 A116V and
VP3 A118V mutants (6.87 and 6.93, respectively). Overall, these
results support the hypothesis that the N terminus of VP1 and the
pentameric capsid interface modulate FMDV acid sensitivity.
These findings are also consistent with previous observations
showing that the combination of different amino acid replace-
ments in FMDV capsid can induce additive effects on pH stability
(12).
Regarding the N terminus of VP1, different amino acid re-
placements associated with an increase in acid resistance of the
capsid have beendescribed for FMDVs from typeA (22), C (10),O
(23), or Asia1 (24). However, to our knowledge, no evidence for
amino acid replacements in this region that increase acid lability is
available. In addition to a pseudorevertant virus, VP1D17G virus,
selected as a result of passage of the VP1 N17D mutant in the
presence of NH4Cl, we found a series of amino acid replacements
involving five positions within the N terminus of VP1 (V11, T12,
Y18, and T22 in type C FMDV and T12 and T2 in type O FMDV).
Two of these positions, T2 andV11, have been described as invari-
ant among FMDV serotypes (3). Interestingly, three different sub-
FIG 4 Analysis of amino acid substitutions selected in C-S8c1 variants passaged in the presence of NH4Cl. (A) Inside schematic view of a pentameric subunit in
the capsid of C-S8c1 displaying the location of amino acid residues found to be substituted in FMDVpopulations passaged in the presence of NH4Cl. The groups
of substitutions located at the VP1N terminus or at the pentameric interface are encircled. Only amino acidmain chains are shown, for clarity. VP1 is green, VP2
is magenta, VP3 is cyan, and VP4 is yellow. (B to D) Acid sensitivity profiles of viruses recovered from infectious clone pMT28 and its derivatives engineered to
carry nucleotide substitutions found in FMDV variants passaged in the presence of NH4Cl. Each engineered virus is compared with its parental virus. Acid
inactivation assays were carried out as described in Materials and Methods and in the legend to Fig. 2. Infectivity was calculated as the percentage of PFU
recovered at each different pH relative to that obtained at pH 7.4. The intersection between the inactivation curves and the dashed line indicates pH50 values; see
the text for details.
TABLE 2Mutations selected in the capsid coding region of type O
FMDV mutants isolated in the presence of NH4Cl
Clone
Mutation(s) found in viral capsid proteina
VP4 VP2 VP3 VP1
fc4 C2924A T12N
fc9 A2695G T156A
fc11 A2695G T156A
fc13 A2893G T2A
a The nucleotide position in the O1K genome (30) and the substitution found in
individual viral clones obtained after virus plating in the presence of 25 mM NH4Cl are
displayed. For nonsynonymous substitutions, amino acid replacements are shown in
bold.
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stitutions at residue T12 (alanine and isoleucine in type C and
asparagine in type O) were found in acid-labile mutants. The N
terminus of VP1 is important for picornavirus uncoating, includ-
ing the acid-resistant enteroviruses (40). In acid-labile picornavi-
ruses such as rhinoviruses, this region is involved in capsid-RNA
interactions and is externalized from the capsid during uncoating
(41, 42). Indeed, in the aphthovirus equine rhinitis A virus, which
is phylogenetically closely related to FMDV, the N terminus of
VP1 also undergoes structural rearrangements when viral parti-
cles are exposed to acidic pH (43). However, onemust be cautious
with these comparisons because both rhinoviruses and equine rhi-
nitis A virus undergo conformational rearrangements during cap-
sid dissociation, changes that have not been reported for FMDV.
Indeed, the current model for FMDV disassembly points to a di-
rect dissociation of the capsid into pentameric subunits without
the occurrence of any uncoating intermediate. In any case, a role
of the VP1 N terminus in capsid stability and FMDV uncoating
could resemble evolutionarily shared features in the picornavi-
ruses for capsid disassembly. This general feature beneath a uni-
fied mechanism for picornavirus cell entry should be shared from
acid-resistant enteroviruses to acid-labile picornaviruses such as
rhinoviruses or FMDV (43). Additional evidence of the involve-
ment of the N terminus of VP1 in capsid stability is provided by
the observation that FMDV empty capsids display a disordered
VP1 N terminus, which may be related to the different acid sensi-
tivities of empty capsids and virions (9). Amino acid substitution
VP3 T156A, observed in two type O acid-labile mutants, was
mapped very close to the VP1 N terminus. According to the con-
tact information available at VIPERdb (34), residue VP3 T156 can
establish contacts with VP1 V11 and T13, suggesting that muta-
tions in this residue can affect the function of the VP1N terminus.
Such potential interaction is also observed for type C FMDV, in
which VP1 V11, which maps very close to residue VP3 T155, the
position equivalent to T156 in type O FMDV, was replaced by
isoleucine in an acid-labile mutant. Overall, the results obtained
with type C FMDV were reinforced by the detection of mutants
within the VP1 N terminus of type O FMDV, supporting the no-
tion that capsid stability is regulated by common mechanisms in
these two serotypes (10, 23). Nevertheless, the contribution to the
acid stability of FMDV virions of capsid regions other that those
described here remains to be addressed.
Mechanistically, the current model for FMDV uncoating pro-
poses that protonation of two histidine residues located in VP3
(H140 andH143 orH141 and 144 in type C andOFMDV, respec-
tively) provides the pH-dependent switch for capsid dissociation
(7, 9, 44, 45). The protonation of these residues introduces an
electrostatic repulsion with the dipole of an alpha helix in the
neighboring pentamer, facilitating capsid dissociation. Themuta-
tions in the VP1 N terminus or at the pentameric interface iden-
tified in this study could modulate this mechanism, altering the
uncoating pH threshold. In addition, amino acid residues of VP1
N terminus T2, V11, T12, and N17, which were replaced in these
mutants, interact with different amino acid residues of VP4. Since
FMDV dissociates into pentameric subunits releasing RNA and
VP4 (46), the amino acid replacement here described could also
modulate this process, contributing to the alterations of the acid
lability of viral capsid observed. It is remarkable that different
amino acid substitutions located at the N terminus of VP1 could
result in diverse phenotypes, which could be explained by the
residues involved and the replacements selected. Thus, N17D was
the only replacement that resulted in an increase in acid resistance.
This is a nearly isosteric replacement (11) leading to the introduc-
tion of a negatively charged amino acid, which could partially
neutralize the positive charge of the protonatedH143, resulting in
an increase in acid resistance (11). Supporting this hypothesis, the
pseudorevertant virus carrying D17G restored the uncharged na-
ture of the residue and rendered a virus more acid labile than its
parental virus carrying N17D. Conversely, replacement Y18H,
found in an acid-labile mutant, introduced a protonable residue
that could result in an increase of the positive charge of VP1 N
terminus region at acidic pH. Nevertheless, no alteration in the
charge balance of the N terminus was observed in the remaining
FIG 5 Characterization of type O FMDV mutants isolated in the presence of
NH4Cl. (A) Inside schematic view of a pentameric subunit in the capsid of type
O FMDV displaying the location of amino acid residues found to be substi-
tuted in mutants isolated in the presence of 25 mM NH4Cl. Only amino acid
main chains are shown for clarity. The location of VP1 N17 is also indicated.
VP1 is green, VP2 is magenta, VP3 is cyan, and VP4 is yellow. (B) Acid sensi-
tivity profiles of type Omutant viruses isolated in the presence of NH4Cl. Acid
inactivation assays were carried as described in Materials and Methods and in
the legend to Fig. 2. Infectivity was calculated as the percentage of PFU recov-
ered at each different pH relative to that obtained at pH 7.2. The intersection
between the inactivation curves and the dashed line indicates pH50 values; see
the text for details.
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mutants isolated. Thus, while replacements T2A and T12A re-
sulted in a loss of lateral side chains, substitutions V11I, T12I,
T12N, andT22N introduced amino acid residueswith bulkier side
chains. It should be noted that all the replacements found in the N
terminus of VP1 affected amino acid residues that interact with
multiple residues located in VP4 and also in VP2 and VP3. Thus,
the complexity of the interactions established by the residues lo-
cated at the N terminus of VP1 could explain why different amino
acid replacements can result in opposed phenotypes.
In summary, our results have revealed a functional relation-
ship between two distant capsid regions that modulate the acid
stability of the FMDV capsid. These findings suggest that capsid
stability behaves as a multifactorial trait that is the fine-tuned
product of a complex interaction between different capsid pro-
teins.
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